115 related articles for article (PubMed ID: 6854093)
1. [Pregnancy-associated alpha 2-glycoprotein in patients with gynecologic cancer].
Sawada M; Matsui Y; Okudaira Y; Shimizu Y; Takayama K
Nihon Sanka Fujinka Gakkai Zasshi; 1983 Apr; 35(4):451-8. PubMed ID: 6854093
[TBL] [Abstract][Full Text] [Related]
2. [Immunosuppressive acidic protein in patients with gynecologic cancer].
Sawada M; Matsui Y; Okudaira Y; Shimizu Y; Takayama K
Nihon Sanka Fujinka Gakkai Zasshi; 1983 May; 35(5):605-11. PubMed ID: 6408203
[TBL] [Abstract][Full Text] [Related]
3. Significance of pregnancy-associated alpha 2-glycoprotein (alpha 2-PAG) in patients with breast, gastric and colorectal cancer.
Shimizu Y; Oshima K; Nakano Y; Fujita M; Taguchi T
Biken J; 1981 Sep; 24(3):95-102. PubMed ID: 6175310
[TBL] [Abstract][Full Text] [Related]
4. [Variations in the level of immunosuppressive acidic protein in patients with gynecologic tumors and pregnant women].
Sawada M; Okudaira Y; Matsui Y; Miyoshi Y; Takayama K; Shimizu Y; Miura S
Gan To Kagaku Ryoho; 1983 Aug; 10(8):1823-30. PubMed ID: 6882005
[TBL] [Abstract][Full Text] [Related]
5. [Behavior of the serum concentration of pregnancy associated alpha 2 glycoprotein (alpha 2-PAG) in gynecologic carcinomas (author's transl)].
Tatra G
Strahlentherapie; 1981 Jul; 157(7):464-7. PubMed ID: 7268817
[TBL] [Abstract][Full Text] [Related]
6. [Clinical significance of new tumor marker CA 125 in gynecological cancer--particularly usefulness in diagnosis of ovarian cancer].
Kimura E; Murae M; Koga R; Odawara Y; Nakabayashi Y; Yokoyama K; Nakata H; Totake T; Ochiai K; Yasuda M
Nihon Sanka Fujinka Gakkai Zasshi; 1984 Nov; 36(11):2121-8. PubMed ID: 6595320
[TBL] [Abstract][Full Text] [Related]
7. [Clinical significance of sialic acid determinations in patients with gynecologic cancer].
Shimizu Y; Akagaki E; Hirota K; Kono M; Irie T; Miura S; Kurachi K; Okudaira Y
Nihon Sanka Fujinka Gakkai Zasshi; 1987 Jan; 39(1):49-55. PubMed ID: 3819514
[TBL] [Abstract][Full Text] [Related]
8. Clinical value of sialyl Tn antigen in patients with gynecologic tumors.
Inoue M; Ogawa H; Nakanishi K; Tanizawa O; Karino K; Endo J
Obstet Gynecol; 1990 Jun; 75(6):1032-6. PubMed ID: 2342728
[TBL] [Abstract][Full Text] [Related]
9. Soluble urokinase plasminogen activator receptor in preoperatively obtained plasma from patients with gynecological cancer or benign gynecological diseases.
Riisbro R; Stephens RW; Brünner N; Christensen IJ; Nielsen HJ; Heilmann L; von Tempelhoff GF
Gynecol Oncol; 2001 Sep; 82(3):523-31. PubMed ID: 11520150
[TBL] [Abstract][Full Text] [Related]
10. [Significance of CA 125 antigen levels in patients with ovarian cancer].
Shimizu Y; Fujiwara H; Akagaki E; Hirota K; Kono M; Irie T; Miura S; Okudaira Y
Gan To Kagaku Ryoho; 1986 Jan; 13(1):46-52. PubMed ID: 3455806
[TBL] [Abstract][Full Text] [Related]
11. [Tissue polypeptide antigen as a tumor marker for gynecologic malignancies].
Inoue M; Fujita Y; Abe Y; Inoue Y; Ueda G; Tanizawa O; Minagawa J; Yamada T; Ohashi K; Ozaki M
Nihon Sanka Fujinka Gakkai Zasshi; 1985 Sep; 37(9):1799-805. PubMed ID: 4056529
[TBL] [Abstract][Full Text] [Related]
12. [Evaluation of serum ferritin in female genital neoplasms].
Dong MY
Zhonghua Fu Chan Ke Za Zhi; 1991 Jan; 26(1):21-3, 61. PubMed ID: 1848498
[TBL] [Abstract][Full Text] [Related]
13. [Isoelectroforetic analysis of alpha 1-acid glycoprotein (alpha 1-AG) in gynecological malignancy].
Kasuga K
Nihon Sanka Fujinka Gakkai Zasshi; 1983 Apr; 35(4):498-506. PubMed ID: 6304211
[TBL] [Abstract][Full Text] [Related]
14. [Serum ferritin and trophoblastic globulin in genital tumors in women].
Griaznova IM; Borisenko SA; Markarov OV; Fomina MB; Prokopenko PG; Tatarinov IuS
Vopr Onkol; 1990; 36(2):181-7. PubMed ID: 2180208
[TBL] [Abstract][Full Text] [Related]
15. [The clinical significance of tissue polypeptide antigen (TPA) in the patients with gynecologic tumor].
Inoue M; Inoue Y; Hiramatsu K; Tanaka Y; Yamasaki M; Ueda G; Minagawa J; Ozaki M; Yanagida T; Nishino H
Nihon Sanka Fujinka Gakkai Zasshi; 1984 May; 36(5):779-84. PubMed ID: 6736725
[TBL] [Abstract][Full Text] [Related]
16. [Regulation of ceruloplasmin activity in oncogynecological diseases].
Gusarova IuN; Stepanova EV; Landesman EO; Koroleva OV; Vavilova TP; Makarov OV; Kosetskiĭ VN
Vopr Med Khim; 2002; 48(4):388-93. PubMed ID: 12506616
[TBL] [Abstract][Full Text] [Related]
17. [Transient form of serum albumin in gynecologic cancer].
Rybalka AN; Bagdasar'ian SN; Garina TN; Karpilenko TM; Kasymova GA
Biull Eksp Biol Med; 1984 Jan; 97(1):76-9. PubMed ID: 6692030
[TBL] [Abstract][Full Text] [Related]
18. An investigation of relationships between hypoxia-inducible factor-1 alpha gene polymorphisms and ovarian, cervical and endometrial cancers.
Konac E; Onen HI; Metindir J; Alp E; Biri AA; Ekmekci A
Cancer Detect Prev; 2007; 31(2):102-9. PubMed ID: 17418979
[TBL] [Abstract][Full Text] [Related]
19. [CA 125 (cancer antigen 125), a new tumor associated antigen recognized by monoclonal antibody].
Suzuki H; Teshima K; Noda K
Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2719-23. PubMed ID: 6594978
[TBL] [Abstract][Full Text] [Related]
20. A study on the serum pregnancy zone protein levels in pregnant women and patients with gynecological tumors.
Teng H; Zhang WY; Zhu FQ
Chin Med J (Engl); 1994 Dec; 107(12):910-4. PubMed ID: 7882729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]